Morganna Freeman, DO, FACP from The Angeles Clinic and Research Institute points out the need for early detection and intervention with many of the side effects seen from immunotherapy treatments.
Using colitis as an example, Freeman discusses what could happen if adverse events go unattended. This could result in long-term hospitalization or more severe medication for the patient. However, earlier reporting and intervention could prevent even hospitalization.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.